President Trump’s “America First” strategy – also described as “Hemispheric Defense” and alignes with the century-long Monroe Doctrine of the early 1800s – has expanded through increased border security, elevated pressure on allies such as Canada and Mexico, punitive measures against adversaries including China, Venezuela, Colombia, and Afghanistan, and declaring fentanyl crisis as well as both a public health crisis and national security threat, while also expanding list of nations designated as major drug transit or illicit drug-producing countries.
A White House statement to begin the week announced that the Trump administration invoked Section 706(1) of the Foreign Relations Authorization Act for Fiscal Year 2003 (Public Law 107-228) to designate Afghanistan, The Bahamas, Belize, Bolivia, Burma, the People’s Republic of China (PRC), Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru, and Venezuela as major drug transit or illicit drug-producing countries.
Trump’s new designation for the countries listed above provides the administration with additional leverage, including the ability to impose severe consequences on foreign assistance programs if those governments fail to meet counterdrug obligations.
In effect, the designation gives Trump another bold tool to bring into line countries it views as complicit in the global drug trade network with drugs that eventually end up on the streets of U.S. cities, which have fueled an overdose crisis killing more than 100,000 Americans annually.
Hellbound and Down 